Advanced RIKA Plasma Donation System Enhances Donor Experience at CSL Plasma Centers in Denver, Colorado

DENVER, Colorado – November 20, 2024 – CSL Plasma, a leader in plasma donation that creates life-saving medicines, has introduced the Rika Plasma Donation SystemTM to the six plasma centers in the Denver, Colorado area. This cutting-edge technology reflects CSL Plasma’s continued commitment to providing an efficient, best-in-class experience for donors.

“Every day, our donors ‘Do the Amazing’ by donating plasma to help those who are in crucial need for therapies made from plasma,” said Steve Marlow, General Manager and Senior Vice President, CSL Plasma. “Without plasma donors, we are unable to produce these products that provide a better quality of life for individuals who need them. We are constantly working to provide the latest technology for our donors to provide them with a rewarding donor experience, and we are excited to continue to roll out this technology in more communities across the United States.”

The Rika Plasma Donation System, only available at CSL Plasma and developed by Terumo Blood and Cell Technologies (based in Lakewood, Colorado), completes an average plasma collection in around 35 minutes, which is on average 15 minutes quicker than donations on other plasmapheresis machines. At the same time, the system ensures there is no more than 200 milliliters of blood outside the donor’s body at one time, helping improve comfort during the donation process.

CSL Plasma is excited to continue to expand availability of the Rika system to additional locations across the country. More than half of all U.S.- and Puerto Rico-based CSL Plasma centers are currently on the Rika system. This initiative underscores CSL Plasma’s ongoing dedication to enhancing the donor experience and demonstrates the company’s leadership in innovation within the field.

"After a very serious health scare 30 years ago, I have been regularly treated with plasma-based medicines which have allowed me to live a good, productive life,” said Dr. Peter Atherton, who is one of CSL Plasma's Patients and Life-savers (P.A.L.S.) in the Denver area. “Thanks to doctors, scientists, medicine manufacturers and plasma donors, I was able to see my children grow up, get married, have children and watch them grow up. "Because of plasma donations, I've had the opportunity to work in progressive leadership roles, help children in need as a Court Appointed Special Advocates (CASA) volunteer and have a seat on the Immune Deficiency Foundation (IDF) board. Plasma donations have given me the opportunity to be here to tell donors how their donations save and change lives."

To donate at a CSL Plasma donation center, donors must be in good health, between the ages of 18 and 65, weigh at least 110 pounds, have no new tattoos or piercings within the last four months, meet eligibility and screening requirements, and have valid identification and a permanent address. Learn more about donating plasma and CSL Plasma Careers at cslplasma.com.

About Plasma
Plasma, the liquid component of blood, is rich in proteins, antibodies, clotting factors and essential nutrients. These components play a critical role in treating a variety of medical conditions, including trauma, shock, burns and other emergencies. Plasma-derived therapies are particularly valuable in addressing complex health needs, such as those of women and young mothers during pregnancy and delivery. These therapies can also provide life-saving treatments for a range of chronic and rare conditions, including immune deficiencies, hemophilia, and other bleeding and neurological disorders.

About CSL Plasma
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with approximately 350 plasma collection centers in the U.S. and Europe. Headquartered in Boca Raton, Florida, CSL Plasma is a subsidiary of CSL Behring, a global biotherapeutics business and a member of CSL.

Plasma collected at CSL Plasma facilities is used by CSL Behring for the sole purpose of manufacturing lifesaving plasma-derived therapies for people in more than 100 countries. This includes people who rely on plasma-derived therapies that treat diseases such as primary immune deficiencies, hereditary angioedema, inherited respiratory disease, hemophilia and other bleeding and neurological disorders. The parent company CSL (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs 32,000 people. For more information about CSL Plasma visit, cslplasma.com.

About Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies is a medical technology company. We have a portfolio of products, software and services for blood collection, therapeutic apheresis and cellular technologies enabling customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today.

Terumo Blood and Cell Technologies customers include blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing organizations, researchers and private medical practices. Our customers are based in over 130 countries across the globe. The company works to improve patient outcomes by providing innovations that address unmet medical needs.

Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology. www.terumobct.com

 

Media Contacts
Nate Wardle
Director of Communications, CSL Plasma
nate.wardle@cslplasma.com

Christine Romero
Corporate Communications
Christine.Romero@terumobct.com press@terumobct.com